Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015

September 22, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)- Purchase of land situated at Patibulum Village, Kancheepuram District, Tamil Nadu. Dear Sir/Madam, With reference to the captioned subject and our earlier intimation dated June 06, 2025, regarding the disposal of dispute, in relation to the lease rental of subjected property, we wish to inform you that the Company has purchased the said property. The purchase of aforesaid property has resulted in conclusion of the erstwhile lease arrangement and cessation of DBS Banks’s rights and interest in the said property. The aforesaid transaction therefore marks the permanent closure of the Company’s arrangement with DBS Bank India Limited in relation to the said property, thereby providing certainty and clarity with respect to the Company’s ownership of the said property You are requested to take the above on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Membership No.: F10698